recurrent childhood acute myeloid leukemia
|
disease |
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hypercellular bone marrow
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Abnormal dense granule content
|
phenotype |
|
Anatomical Abnormality
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormal alpha granule content
|
phenotype |
|
Anatomical Abnormality
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Multiple cranial nerve palsy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Acute lymphoblastic leukemia, in relapse
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Inherited platelet disorder
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Autoimmune lung disease
|
disease |
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Abnormal basophil morphology
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Platelet Disorder, Familial, with Associated Myeloid Malignancy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
4
|
20
|
0.730 |
definitive |
1.000 |
31 |
20
|
1998 |
2019 |
Alpha-Thalassemia Myelodysplasia Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
4
|
3
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Acute myeloid leukemia, inv(16)(p13q22)
|
disease |
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Acute myeloblastic leukemia with t(8;21)
|
disease |
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
familial acute myeloid leukemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Trisomy 15
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Acute myeloid leukemia with recurrent genetic abnormality
|
disease |
Neoplasms
|
Neoplastic Process
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Acute myeloid leukemia with multilineage dysplasia
|
disease |
Neoplasms
|
Neoplastic Process
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Tetrasomy 21
|
disease |
|
Disease or Syndrome
|
6
|
|
0.030 |
None |
1.000 |
3 |
|
2000 |
2004 |
Blood Group Incompatibility
|
disease |
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
AML M5b
|
disease |
|
Neoplastic Process
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Leukemic Infiltration
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Congenital amegakaryocytic thrombocytopenia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Congenital Abnormality
|
7
|
25
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Myelodysplastic Syndrome Acute Myeloid Leukemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Neoplastic Process
|
8
|
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2018 |
Histiocytosis, Non-Langerhans-Cell
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
9
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Acute myeloid leukaemia progression
|
disease |
|
Neoplastic Process
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |